Eyenovia (EYEN) News Today $1.26 0.00 (0.00%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.24 -0.02 (-1.98%) As of 03/27/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Eyenovia (NASDAQ:EYEN) Given "Neutral" Rating at HC WainwrightMarch 23, 2025 | americanbankingnews.comEyenovia enters non-binding LOI to effect reverse merger with BetaliqMarch 21, 2025 | markets.businessinsider.comEyenovia Shares Drop 14% Amid Betaliq Merger TalksMarch 21, 2025 | finance.yahoo.comEyenovia Plans All-Stock Reverse Merger With BetaliqMarch 20, 2025 | marketwatch.comEyenovia falls on plans to seek reverse mergerMarch 20, 2025 | msn.comEyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with BetaliqMarch 20, 2025 | globenewswire.comEyenovia regains compliancce with Nasdaq Stock MarketFebruary 26, 2025 | markets.businessinsider.comEyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On?February 26, 2025 | benzinga.comEyenovia Regains Compliance with All Nasdaq Continued Listing RequirementsFebruary 26, 2025 | globenewswire.comEyenovia announces debt restructuring, improving cash runwayFebruary 24, 2025 | markets.businessinsider.comEyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic AlternativesFebruary 24, 2025 | globenewswire.comWainwright maintains neutral Eyenovia stock, $2 targetFebruary 6, 2025 | msn.comEyenovia announces progress on next-gen user-filled OptejetFebruary 6, 2025 | markets.businessinsider.comEyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing DeviceFebruary 5, 2025 | globenewswire.comEyenovia enacts reverse stock split to meet Nasdaq requirementsFebruary 1, 2025 | msn.comEyenovia trading halted, news pendingJanuary 31, 2025 | markets.businessinsider.comEyenovia, Inc.: Eyenovia Announces 1-for-80 Reverse Stock SplitJanuary 29, 2025 | finanznachrichten.deEyenovia Announces 1-for-80 Reverse Stock SplitJanuary 28, 2025 | globenewswire.comEyenovia shareholders approve reverse stock split and additional stock reserveJanuary 24, 2025 | msn.comEyenovia announces advisory firms recommend vote ‘FOR’ reverse stock splitJanuary 16, 2025 | markets.businessinsider.comEyenovia secures $1 million from warrant repricing and exerciseJanuary 16, 2025 | msn.comEyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of StockholdersJanuary 15, 2025 | globenewswire.comEyenovia (NASDAQ:EYEN) Stock Quotes, Forecast and News SummaryJanuary 12, 2025 | benzinga.comEyenovia Hires Financial Adviser Amid Business ReviewJanuary 6, 2025 | marketwatch.comEyenovia Engages Chardan as Advisor for Review of Strategic AlternativesJanuary 6, 2025 | globenewswire.comEyenovia’s $1.9M Offering to Boost Optejet DevelopmentDecember 9, 2024 | markets.businessinsider.comEyenovia Prices $1.9 Mln Registered Direct OfferingDecember 9, 2024 | markets.businessinsider.comEyenovia announces pricing of $1.9M registered direct offeringDecember 6, 2024 | markets.businessinsider.comEyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct OfferingDecember 6, 2024 | globenewswire.comEyenovia defers loan payments, issues equity to lendersNovember 27, 2024 | uk.investing.comEyenovia Slumps On Pricing Of Registered Direct OfferingNovember 27, 2024 | nasdaq.comEyenovia’s Direct Offering to Support Strategic InitiativesNovember 26, 2024 | markets.businessinsider.comEyenovia to sell 12.1M shares at 10.76c in registered direct offeringNovember 26, 2024 | markets.businessinsider.comEyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct OfferingNovember 25, 2024 | finance.yahoo.comEyenovia taking additional actions to reduce personnel-related costs by over 70%November 23, 2024 | finance.yahoo.comEyenovia, Inc.: Eyenovia Provides Update on Restructuring EffortsNovember 22, 2024 | finanznachrichten.deEyenovia Provides Update on Restructuring EffortsNovember 22, 2024 | globenewswire.comLadenburg Thalmann Downgrades Eyenovia (EYEN)November 20, 2024 | msn.comEyenovia downgraded to Neutral from Buy at LadenburgNovember 20, 2024 | markets.businessinsider.comEyenovia downgraded to Neutral from Buy at H.C. WainwrightNovember 20, 2024 | markets.businessinsider.comEyenovia stock plummets following Phase III myopia trial failureNovember 19, 2024 | msn.comEyenovia downgraded to Hold from Buy at BrooklineNovember 15, 2024 | markets.businessinsider.comEyenovia downgraded to Market Perform from Outperform at William BlairNovember 15, 2024 | markets.businessinsider.comEyenovia to Cut 50% of Workforce After Phase 3 Study DisappointsNovember 15, 2024 | marketwatch.comEyenovia to End Eye Drug Study, Cut 50% of Its WorkforceNovember 15, 2024 | money.usnews.comEyenovia Mulls Options After Phase 3 Study FailureNovember 15, 2024 | marketwatch.comEyenovia plans to terminate Phase 3 CHAPERONE study after DRC reviewNovember 15, 2024 | markets.businessinsider.comEyenovia Shares Plumb New Depths After Study FailureNovember 15, 2024 | marketwatch.comEyenovia Third Quarter 2024 Earnings: Misses ExpectationsNovember 15, 2024 | finance.yahoo.comEyenovia to end eye drug study after missing late-stage goal, shares fallNovember 15, 2024 | msn.com Remove Ads Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address EYEN Media Mentions By Week EYEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EYEN News Sentiment▼0.490.78▲Average Medical News Sentiment EYEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EYEN Articles This Week▼62▲EYEN Articles Average Week Remove Ads Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BFRI News Today OMGA News Today ALZN News Today ALBT News Today GTBP News Today SNGX News Today AEZS News Today CANF News Today FRTX News Today NLSP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EYEN) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eyenovia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eyenovia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
